as on March 6, 2026 at 9:31 pm IST
Day's Low
Day's High
3.01%
Downside
0.87%
Upside
52 Week's Low
52 Week's High
26.58%
Downside
22.06%
Upside
as on March 6, 2026 at 4:01 pm IST
Market Cap
₹955.77 Cr
Return on Equity (ROE)
19.48
PE Ratio (TTM)
10.88
Return on capital employed (ROCE)
17.61
Industry PE ratio
41.51
Beta (LTM)
0.94
P/B Ratio
2.1
Dividend Yield
0.91
PEG Ratio
0.62
Quarterly Earnings Growth YOY
-68.28
EPS (TTM)
26.19
Sector
Pharmaceuticals
Book Value
124.33
Technical Analysis
Bullish
View Technical Analysis
as on March 6, 2026 at 4:01 pm IST
Fermenta Biotech in the last 5 years
Lowest (-55.80x)
October 6, 2022
Today (10.88x)
March 5, 2026
Industry (41.51x)
March 5, 2026
Highest (473.02x)
September 6, 2022
Today’s Price to Earnings Ratio: 10.88x
Compare market cap, revenue, PE, and other key metrics of Fermenta Biotech with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 955.77 | 1.96% | 0.64 | 76 | 469 | |
| NA | 11.00 | 56.07% | 0.00 | -1 | 21 | |
| NA | 873.48 | 31.71% | 0.88 | 30 | 599 | |
| HOLD | 3,293.02 | -9.57% | 0.66 | 168 | 2,387 | |
| NA | 2,581.75 | 4.22% | 0.68 | 3 | 2,711 |
Search interest for Fermenta Biotech Ltd Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Fermenta Biotech.
Fermenta Biotech Ltd’s net profit fell -65.65% since last year same period to ₹12.68Cr in the Q3 2025-2026. On a quarterly growth basis, Fermenta Biotech Ltd has generated -29.79% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Fermenta Biotech Ltd has declared dividend of ₹2.50 per share on 28 May 2025 - translating a dividend yield of 0.77%.
Read More about DividendsCheck stock indices that include Fermenta Biotech.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 135.66 Cr → 140.48 Cr (in ₹), with an average increase of 3.4% per quarter
Price Rise
![]()
In the last 3 months, Fermenta Biotec. stock has moved up by 22.7%
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 42.3% return, outperforming this stock by 20.5%
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 189.8% return, outperforming this stock by 59.4%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 64.09% of holdings in Dec 2025 quarter
FII Holding Unchanged
![]()
Foreign Institutions holdings remained unchanged at 0.02% of holdings in Dec 2025 quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 34.75% to 33.99% in Dec 2025 quarter
Profit Down
![]()
Netprofit is down for the last 5 quarters, 36.91 Cr → 12.68 Cr (in ₹), with an average decrease of 22.6% per quarter
| Organisation | Fermenta Biotech Ltd |
| Industry | Pharmaceuticals |
| CEO | Pradeep Manjunath Chandan |
| E-voting on shares | Click here to vote |
Fermenta Biotech share price today stands at ₹326.9 as on at the close of the market. Fermenta Biotech share today touched a day high of ₹329.75 and a low of ₹317.05.
Fermenta Biotech touched a 52 week high of ₹399 and a 52 week low of ₹240. Fermenta Biotech share price today i.e. is closed at ₹326.9, which is -18.07% down from its 52 week high and 36.21% up from its 52 week low.
Fermenta Biotech market capitalisation is ₹955.77 Cr as on .
To buy Fermenta Biotech shares, you need to follow these steps:
Fermenta Biotech trading volume is 3,805.00 as on . This means that 3,805.00 shares of Fermenta Biotech were bought and sold on the stock market during today's trading session.